Bio Essence Corporation
BIOE
$0.0937
$0.00272.97%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 7,419.48% | 64.70% | -41.25% | -104.85% | -101.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7,419.48% | 64.70% | -41.25% | -104.85% | -101.23% |
| Cost of Revenue | 26.01% | -61.98% | -62.54% | -37.78% | 93.72% |
| Gross Profit | 663.36% | 82.99% | 67.13% | -23.42% | -76.50% |
| SG&A Expenses | 100.51% | 58.59% | 95.72% | -71.86% | -43.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 339.50% | 81.56% | 126.71% | -103.61% | -70.98% |
| Operating Income | 30.37% | -8.37% | -32.94% | 60.58% | -8.29% |
| Income Before Tax | -214.36% | -227.66% | -288.34% | -139.65% | -0.18% |
| Income Tax Expenses | 200.00% | -50.00% | -50.00% | -132.00% | -132.00% |
| Earnings from Continuing Operations | -215.13% | -226.78% | -287.00% | -138.43% | 0.57% |
| Earnings from Discontinued Operations | 100.00% | 100.00% | 145.28% | 0.77% | 0.77% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -132.59% | -150.13% | -34.69% | -48.79% | 32.59% |
| EBIT | 30.37% | -8.37% | -32.94% | 60.58% | -8.29% |
| EBITDA | 32.63% | -8.87% | -34.48% | 54.05% | -15.04% |
| EPS Basic | -112.35% | -122.56% | -21.48% | -42.40% | 34.62% |
| Normalized Basic EPS | 26.39% | -11.36% | -16.67% | 35.71% | 10.00% |
| EPS Diluted | -112.35% | -122.56% | -21.48% | -42.40% | 34.62% |
| Normalized Diluted EPS | 26.39% | -11.36% | -16.67% | 35.71% | 10.00% |
| Average Basic Shares Outstanding | 2.74% | 5.08% | 8.84% | 6.66% | 10.65% |
| Average Diluted Shares Outstanding | 2.74% | 5.08% | 8.84% | 6.66% | 10.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |